4 CHAIRMANS STATEMENT I am delighted to announce record group results in terms of both revenue and profit for the year ended 30th June 2011. cHaIrmans statement Total group revenue for the year was 288.7m including whose laser scanner products are primarily marketed in the 8.9m revenue from acquisitions during the year 2010 nil, areas of marine positioning, mining, quarrying and surveying.
59% ahead of the 181.6m for last year and, more importantly, On 8th April 2011, the Group acquired for 3.8m, a 100% 43% above the previous highest years revenue of 201.2m shareholding in MTT Investments Limited MTT.
All geographic areas saw good progress, with designs, develops and manufactures additive manufacturing growth of 64% in Europe, 57% in the Americas and 61% in the and rapid prototyping systems, including selective laser melting, Far East, particularly in China, which has become the Groups metal casting, and vacuum casting machines and processes.
largest market, with revenues of 54.2m this year Based in Stone, Staffordshire, in the UK, MTT has 40 2010 34.2m.
employees, with subsidiaries in the USA and Italy, and a branch Group profit before tax for the year, excluding exceptional office in France.
MTTs selective laser melting equipment items, was 80.4m, compared with 28.7m last year, and currently has its main markets in aerospace and medical compared with 41.7m in 2008, being the previous highest devices, but also has potential for use in other sectors.
Its years profit before tax excluding exceptional items.
products are complementary to Renishaws existing Adjusted earnings per share were 88.0p, an increase of technologies and business.
Its results have been consolidated 178% over last years adjusted earnings per share of 31.6p.
since the date of acquisition.
On 1st July 2011 most of the Reported earnings per share were 90.3p 2010 29.3p.
business and assets were transferred to Renishaw plc and is now operating as the Renishaw additive manufacturing seGmental analysIs products division.
metrology On 16th June 2011, the Group acquired, for a total There was an extremely strong performance by our consideration of 6m, of which 3m is payable in June 2013, metrology business during the year, with revenue of 267.0m, certain calibration technology and software, together with compared with 162.1m last year, an increase of 65%.
There drawings, designs and intellectual property relating to optical was growth across all product lines, with machine tool and technology, from Aberlink Innovative Metrology in order to encoder products showing particularly strong growth.
Operating expand the Groups technology portfolio.
profit for this segment was 87.4m, compared with 31.5m A number of new products have been launched during the last year, an increase of 177%.
year, including Equator, a radical new alternative to traditional During the year the Group acquired a 49% shareholding in dedicated gauging.
This was launched in March 2011 and has Measurement Devices Limited MDL at a cost of 3.9m: been very well received.
there is agreement that MDL will become a 100% subsidiary in 2014.
Accounting standards require the Group to consolidate its results as if the company were a subsidiary, due to the structure of the shareholders agreement.
MDL is a metrology company 5 CHAIRMANS STATEMENT Sir David McMurtry photographed in his office at New Mills, June 2011 6 CHAIRMANS STATEMENT CONTINUED The Group has made very considerable progress during the year.
There continue to be many challenges to be met and overcome, not least the recruitment and absorption of new employees, the occupation of new premises, the integration of newly acquired companies and the ongoing development of Renishaw technologies.
Nevertheless the directors confidently expect the current progress of the Group to continue due to the increased opportunities and the underlying strength of our markets.
Along with 1.6m of tangible fixed assets Our healthcare operations continue to develop both in our acquired through business acquisitions, the net book value of longer established spectroscopy business and in our newer property, plant and equipment increased during the year from dental, neuro and diagnostic activities.
Revenue from our healthcare products rose 11% to The Group has invested heavily in working capital during 21.7m 2010 19.5m.
Certain areas are still in the the financial year.
Inventories have increased by 18.9m over development phase and, as a result of the continuing research the year, including 3.2m relating to acquisitions, as the Group and development costs, an operating loss of 8.5m was has sought to ensure adequate stock to meet customer recorded 2010 loss 3.4m.
demands in an environment of growing but unpredictable and During the year the Group has made several sales of the substantial order intake.
At the end of June 2011, inventories enhanced surgical robot used for neurosurgical procedures.
were 49.8m compared with 30.9m at 30th June 2010.
Renishaw Diagnostics Limited RDL has released the The Group continues to have a solid balance sheet, with RenDx research-use-only RUO multiplex assay system, net cash balances of 34.6m at 30th June 2011, compared providing a highly sensitive and flexible tool to screen for with 31.1m at 30th June 2010. multiple targets in a single analysis.
RDL is preparing to apply for approval of the RenDx multiplex assay system as an in awards vitro medical device.
The Group has received a number of awards during the We continue to develop our dental business, including our year including our 14th Queens Award for Enterprise: collaboration with Biomet 3i, which is now a non-exclusive Innovation 2011.
This has been granted for the TRS2 distributor of Renishaw dental scanning and milling systems.
laser-based tool breakage detection system used on CNC machine tools.
balance sHeet Expenditure for the year on property, plant and equipment Engineering costs was 16.5m, of which 5.4m was in respect of property and Capital expenditure million million 11.1m was in respect of plant and equipment.
Other Land and buildings Expenditure on property included: Research and development Plant and vehicles - The refurbishment of our Charfield premises, purchased in % of revenue 2008, which has been occupied by our dental, neurological m % of and imaging coil product lines together with a team of revenue group software engineers: - Larger premises in Barcelona for our Spanish sales and 35 marketing operation: - Completion of the expansion of our Indian production 30 m facility in Pune which opened in March 2011: and - On 24th June 2011, the Group contracted to purchase 25 461,000 sq ft of premises on a site of 193 acres in Miskin, 15 South Wales, approximately 55 miles from the New Mills 20 head office.
This additional space is being acquired to 15 10 secure manufacturing capacity required to accommodate future growth.
The cost of these new premises will be 10 7.7m, of which 0.7m has been paid as a deposit prior to 5 the year end.
5 The Groups expenditure on plant, equipment and vehicles of 11.1m comprised mainly additional machine tools, other 0 0 production machinery and IT investment to support the 07 08 09 10 11 07 08 09 10 11 31.1 35.4 35.9 30.9 40.0 9.7 5.3 11.0 2.9 16.5 7 1 3 5 2 4 6 1: On 24th June 2011, Renishaw exchanged contracts to 3: The MTT range of additive manufacturing technologies 5: Sir David McMurtry became a Fellow of the Royal Society at acquire the Bosch manufacturing facility in Miskin, South includes the SLM250 Selective Laser Melting machine, which an admissions ceremony held on 15th July 2011.
During the Wales, which offers 461,000 sq ft of existing factory space utilises a pioneering process capable of producing fully dense ceremony he signed the Societys historic Charter Book on a 193 acre site.
metal parts direct from 3D CAD, using a high-powered laser.
which since 1663 has recorded the signatures of each new Fellow and Foreign Member, including such luminaries as 2 The newly refurbished Renishaw facility at Charfield, close to 4: The Dynascan is a 3D mobile mapping system that can be Charles Darwin, Isaac Newton, Stephen Hawking and its New Mills headquarters, has 30,000 sq ft of mainly open mounted onto vehicles and boats to collect data whilst on the Tim Berners-Lee.
plan space and is clad with composite insulated panelling move, enabling huge savings in time and personnel when to reduce energy consumption.
The building accommodates surveying large areas.
6: On 20th July 2011, Dame Janet Trotter, Lord Lieutenant several of the Companys healthcare business divisions of Gloucestershire, presented Renishaw with a Queens dental, neurological and imaging coil products and includes Award for Enterprise in the Innovations category: this is the a high-quality staff restaurant.
Companys 14th Queens Award and its fifth in just eight years.
Staff DiviDenDS The Group workforce has grown from 2,099 at 30th June A final dividend of 24.7p per share will be paid in respect 2010 to 2,675 at the end of June 2011, an increase of 576. of this year, which, together with the interim dividend of 10.3p, Additional staff have been taken on in all areas, both to support gives a total for the year of 35.0p per share, compared with the current increase in production as well as to ensure the 17.6p for last year and 25.4p in 2008, our previous highest ongoing development programmes in our metrology and dividend.
The final dividend will be paid on 17th October 2011 healthcare businesses.
The Group acquired 95 staff through to shareholders on the register on 16th September 2011. the acquisitions of MDL and MTT.
There are currently 267 outstanding vacancies, of which 139 are in the UK and 128 overseas.
Your directors are grateful for the tremendous support and commitment of our staff during a challenging and exciting year.
ProSPectS Sir David R McMurtry, CBE, RDI, FREng, FRS, CEng, FIMechE The Group has made very considerable progress during the Chairman & Chief Executive year.
There continue to be many challenges to be met and 27th July 2011 overcome, not least the recruitment and absorption of new employees, the occupation of new premises, the integration of newly acquired companies and the ongoing development of Renishaw technologies.
